H126 EBITDA up 27%, free cashflow more than doubles
Released
Released
Announcement PDF
17 August 2026
Doctor Care Anywhere Group plc
ARBN: 645 163 873
19-21 Great Portland Street, London, W1W 8QB, United Kingdom
ASX: DOC
Doctor Care Anywhere records 27% growth in
EBITDA and more than doubles free cash flow
H1 2026 Highlights (vs H1 25)
• Revenue growth: Revenue of £20.4m, up 6.3%, of which £0.9m was contributed
by DCA Medicspot (acquired 8 May 2026). Revenue in the existing business grew
1.7%.
• Cash generation: Free cash flow more than doubled to £1.5m and cash grew
60.3% to £7.7m, funding the acquisition from existing resources.
• Operating leverage: EBITDA up 27.1% to £2.6m with margin up 2.1 percentage
points to 12.8%, on revenue up 6.3% to £20.4m*.
• Strategic acquisition: Expanded into the UK weight management market with
the £0.9m acquisition of a business's trade and assets, generating £0.9m of
revenue.
Doctor Care Anywhere Group plc (ASX:DOC, “Doctor Care Anywhere”, “DCA” or “the
Company”), one of the UK’s largest private providers of telehealth services, today
announced its half year results for the six months ended 30 June 2026. The Company
generated free cash flow of £1.5m in the period while broadening its revenue base
beyond its historic insurer channel.
Key activities during the period
• Acquisition of a weight management business. On 8 May 2026 DCA acquired
the platform and related assets of a weight management business for £0.9m,
funded from existing resources, through its newly incorporated subsidiary DCA
Medicspot Ltd. The business contributed £0.9m of revenue from acquisition to 30
June 2026 and operated at approximately breakeven. It gives DCA an immediate
position in GLP-1 weight-loss treatment and ongoing weight management
support, one of the fastest growing areas of private healthcare in the United
Kingdom.
• Partnership with Ramsay Health Care UK. The collaboration gives Ramsay
patients access to self-pay online GP appointments with onward referral into
Ramsay’s network of hospitals and specialists, creating an end-to-end care
pathway from primary to secondary care.
• Continued patient engagement. Consultation volumes were 354,900, up 1.4%.
Repeat patients represented 74.0% of consultations, consistent with the second
half of FY25 and up from 72.9% in H1 25. Approximately three quarters of all
consultations are now delivered to patients who have used the service before.
• Growth in non insurance revenue. Ongoing non insurance revenue accounted
for 11% of total revenue in H1 26, up from 7% in H1 25. Non insurance revenue
comprises subscription revenue as disclosed in note 3 to the half year financial
statements, being corporate and direct to consumer subscription services. On a
pro forma annualised basis, applying DCA Medicspot's current revenue run rate
of approximately £0.5m per month, non insurance revenue would represent
approximately 19% of total revenue. The pro forma assumes current trading rates
continue and is provided for illustration. It is not a forecast.
• Contribution. Contribution grew 8.8% to £8.6m and contribution margin
improved 0.9 percentage points to 42.0%. Contribution is revenue less cost of
sales, principally the cost of the clinicians delivering consultations and services,
and equates to gross profit in the financial statements following the
reclassification applied in the FY25 Annual Report.
• Operating leverage. EBITDA, being operating profit before depreciation and
amortisation, grew 27.1% to £2.6m with margin up 2.1 percentage points to 12.8%.
Total labour cost fell 4.9% while revenue grew 6.3%, reflecting better control over
labour hours and mix following the operating model changes made in the prior
year.
• Net profit. Net profit for the period was £0.6m, up 28.5%, and operating profit
was £1.1m, up 18.6%. The difference between the growth in EBITDA and in
operating profit reflects a higher depreciation and amortisation charge, arising
from the accumulated asset base and the acquired platform rather than any
change in capitalisation.
• Cash and free cash flow. Free cash flow more than doubled to £1.5m and cash
increased 60.3% to £7.7m, after funding the £0.9m acquisition from existing
resources. Free cash flow is net cash from operating activities less payments for
property, plant and equipment and purchases of intangible assets.
• Relief from quarterly reporting. In July 2026, following the Group’s sustained
cash generation, ASX granted the Company relief from the quarterly reporting
requirements of Listing Rules 4.7B and 4.7C.
Laura O’Riordan, Chief Executive Officer of Doctor Care Anywhere, said:
“This half shows a business that is generating cash. Free cash flow more than doubled
to £1.5m, and we completed the acquisition of our new weight management business,
which was funded out of existing cash reserves rather than raising new capital. That
is the test of whether a transformation has worked.
We are also broadening what we do. The weight management business gives us a
position in one of the fastest growing areas of private healthcare, our partnership with
Ramsay Health Care UK connects our primary care service into a secondary care
pathway, and three quarters of our consultations are now delivered to patients who
have used us before.
Thank you to our team, our clinicians and our partners. There is a great deal still to
do, and we start the second half in a stronger position than we started the first.”
This ASX announcement has been authorised for release by the Board of Directors.
- ENDS -
Investor and media enquiries
Matthew Pearson
Investor Relations
Doctor Care Anywhere Group plc
investorenquiries@doctorcareanywhere.com
Engage with the Doctor Care Anywhere management team directly by asking
questions, watching video summaries and seeing what other shareholders have to
say. Navigate to our Interactive Investor hub here:
https://investors.doctorcareanywhere.com/announcements
Subscribe to our news alert service:
https://investors.doctorcareanywhere.com/s/db4283
About Doctor Care Anywhere
Doctor Care Anywhere Group plc is one of the UK's largest private providers of
telehealth services. The Company connects patients to virtual GP consultations,
mental health, physiotherapy, health assessment and weight management services
on its proprietary platform, working with insurers, healthcare providers and corporate
customers and directly with consumers. For further information please refer to the
Company's website, http://www.doctorcareanywhere.com.
APPENDIX: Basis of comparison
Three measures reported for the six months to 30 June 2025 are presented in this
report on a different basis from the one used in the Company’s announcement of 28
August 2025. The changes are presentational and do not affect cash, profit or net
assets in either period. The Company is setting them out here so that the comparison
is clear.
H1 25 measure Reported August
2025
Restated in this
report
Reason
Gross profit
margin
63.3% 41.0% £4.3m of costs
reclassified from
administrative
expenses to cost
of sales, consistent
with the FY25
Annual Report
Contribution
margin
50.9% 41.0% The same
reclassification.
Contribution and
gross profit are
now the same
measure
EBITDA £2.9m underlying £2.1m The August 2025
figure was
presented on an
underlying basis
and excluded
£0.8m of
restructuring
costs. No
underlying
adjustments have
been made in H1
26.
Reconciliations of contribution, EBITDA and free cash flow to the statutory results are
set out in the Appendix 4D and Half Year Report lodged with this announcement.
Forward looking statements
This announcement contains pro forma and forward-looking information, including
the pro forma annualised non insurance revenue set out above. That information is
based on assumptions current at the date of this announcement, including that
current trading rates continue, and involves risks and uncertainties. Actual results may
differ. Doctor Care Anywhere Group plc does not undertake to update it except as
required by law or the ASX Listing Rules.
Share your feedback
Discover